These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9399737)

  • 1. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
    Koh KK; Bui MN; Mincemoyer R; Cannon RO
    Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris.
    Chou ET; Schulman SP; Thiemann DR; Sohn RH; Bellantoni MF; Rade JJ
    Am J Cardiol; 2003 May; 91(10):1240-2. PubMed ID: 12745110
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation, coronary artery disease, and hormones.
    Lobo RA
    Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
    [No Abstract]   [Full Text] [Related]  

  • 6. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
    Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
    J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
    Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
    Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
    Lamon-Fava S; Posfai B; Schaefer EJ
    Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
    Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
    Blum A; Lang N; Peleg A; Vigder F; Israeli P; Gumanovsky M; Lupovitz S; Elgazi A; Ben-Ami M
    Am Heart J; 2003 Feb; 145(2):e7. PubMed ID: 12595862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
    Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
    Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
    Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
    Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
    Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
    Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration.
    Rajtar-Ciosek A; Huras H; Krzysiek J; Reroń A; Wilczak M; Jach R
    Neuro Endocrinol Lett; 2011; 32(3):340-4. PubMed ID: 21670727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of estrogen in type II diabetic postmenopausal women.
    Koh KK; Kang MH; Jin DK; Lee SK; Ahn JY; Hwang HY; Yang SH; Kim DS; Ahn TH; Shin EK
    J Am Coll Cardiol; 2001 Nov; 38(5):1409-15. PubMed ID: 11691516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
    Greany KA; Nettleton JA; Wangen KE; Thomas W; Kurzer MS
    Eur J Clin Nutr; 2008 Dec; 62(12):1419-25. PubMed ID: 17805230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.